CRISPR Therapeutics AG Statistics
Total Valuation
CRSP has a market cap or net worth of $5.21 billion. The enterprise value is $3.58 billion.
Important Dates
The next estimated earnings date is Monday, August 4, 2025, after market close.
| Earnings Date | Aug 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CRSP has 91.75 million shares outstanding. The number of shares has increased by 6.74% in one year.
| Current Share Class | 91.75M |
| Shares Outstanding | 91.75M |
| Shares Change (YoY) | +6.74% |
| Shares Change (QoQ) | +0.56% |
| Owned by Insiders (%) | 0.45% |
| Owned by Institutions (%) | 68.43% |
| Float | 91.33M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 128.74 |
| Forward PS | 82.21 |
| PB Ratio | 2.68 |
| P/TBV Ratio | 2.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 94.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.64, with a Debt / Equity ratio of 0.12.
| Current Ratio | 15.64 |
| Quick Ratio | 15.53 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -19.71% and return on invested capital (ROIC) is -13.58%.
| Return on Equity (ROE) | -19.71% |
| Return on Assets (ROA) | -12.88% |
| Return on Invested Capital (ROIC) | -13.58% |
| Return on Capital Employed (ROCE) | -23.18% |
| Revenue Per Employee | $95,865 |
| Profits Per Employee | -$981,316 |
| Employee Count | 393 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CRSP has paid $3.97 million in taxes.
| Income Tax | 3.97M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.23% in the last 52 weeks. The beta is 1.82, so CRSP's price volatility has been higher than the market average.
| Beta (5Y) | 1.82 |
| 52-Week Price Change | +2.23% |
| 50-Day Moving Average | 42.15 |
| 200-Day Moving Average | 43.40 |
| Relative Strength Index (RSI) | 72.24 |
| Average Volume (20 Days) | 3,764,064 |
Short Selling Information
The latest short interest is 25.54 million, so 27.84% of the outstanding shares have been sold short.
| Short Interest | 25.54M |
| Short Previous Month | 21.41M |
| Short % of Shares Out | 27.84% |
| Short % of Float | 27.97% |
| Short Ratio (days to cover) | 9.74 |
Income Statement
In the last 12 months, CRSP had revenue of $37.68 million and -$385.66 million in losses. Loss per share was -$4.52.
| Revenue | 37.68M |
| Gross Profit | -400.08M |
| Operating Income | -474.40M |
| Pretax Income | -263.15M |
| Net Income | -385.66M |
| EBITDA | -455.24M |
| EBIT | -474.40M |
| Loss Per Share | -$4.52 |
Full Income StatementBalance Sheet
The company has $1.86 billion in cash and $219.36 million in debt, giving a net cash position of $1.64 billion or $17.83 per share.
| Cash & Cash Equivalents | 1.86B |
| Total Debt | 219.36M |
| Net Cash | 1.64B |
| Net Cash Per Share | $17.83 |
| Equity (Book Value) | 1.83B |
| Book Value Per Share | 21.18 |
| Working Capital | 1.75B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$306.47 million and capital expenditures -$1.39 million, giving a free cash flow of -$307.86 million.
| Operating Cash Flow | -306.47M |
| Capital Expenditures | -1.39M |
| Free Cash Flow | -307.86M |
| FCF Per Share | -$3.36 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,259.20% |
| Pretax Margin | -1,013.10% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CRSP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.74% |
| Shareholder Yield | -6.74% |
| Earnings Yield | -7.40% |
| FCF Yield | -5.91% |
Dividend DetailsAnalyst Forecast
The average price target for CRSP is $71.20, which is 25.35% higher than the current price. The consensus rating is "Buy".
| Price Target | $71.20 |
| Price Target Difference | 25.35% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 127.70% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CRSP has an Altman Z-Score of 6.88 and a Piotroski F-Score of 1.
| Altman Z-Score | 6.88 |
| Piotroski F-Score | 1 |
